The following table presents our revenues and operating loss by segments:
|
Evogene
|
Evofuel
|
Biomica
|
Adjustments
|
Total
|
||||||||||||||||
For the Year Ended December 31, 2017
|
||||||||||||||||||||
Revenues
|
$
|
3,247
|
$
|
134
|
$
|
-
|
$
|
-
|
$
|
3,381
|
||||||||||
Operating loss
|
$
|
(21,430
|
)
|
$
|
(313
|
)
|
$
|
(204
|
)
|
$
|
-
|
$
|
(21,947
|
)
|
||||||
Net financing income
|
$
|
1,120
|
||||||||||||||||||
Loss before taxes on income
|
$
|
(20,827
|
)
|
Evogene
|
Evofuel
|
Adjustments
|
Total
|
|||||||||||||
For the Year Ended December 31, 2016
|
||||||||||||||||
Revenues
|
$
|
6,540
|
$
|
-
|
$
|
-
|
$
|
6,540
|
||||||||
Operating loss
|
$
|
(20,168
|
)
|
$
|
(921
|
)
|
$
|
-
|
$
|
(21,089
|
)
|
|||||
Net financing income
|
1,533
|
|||||||||||||||
Loss before taxes on income
|
$
|
(19,556
|
)
|
Evogene
|
Evofuel
|
Adjustments
|
Total
|
|||||||||||||
For the Year Ended December 31, 2015
|
||||||||||||||||
Revenues
|
$
|
11,129
|
$
|
-
|
$
|
-
|
$
|
11,129
|
||||||||
Operating loss
|
$
|
(16,146
|
)
|
$
|
(1,775
|
)
|
$
|
-
|
$
|
(17,921
|
)
|
|||||
Net financing income
|
708
|
|||||||||||||||
Loss before taxes on income
|
$
|
(17,213
|
)
|